Screener
Turn Therapeutics Inc. TTRX EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Turn Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Turn Therapeutics Inc.’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-054490
FAQ
- What is Turn Therapeutics Inc.'s EPS (diluted)?
- Turn Therapeutics Inc. (TTRX) reported EPS (diluted) of -$0.03 in Q1 2026.
- How has Turn Therapeutics Inc.'s EPS (diluted) changed year-over-year?
- Turn Therapeutics Inc.'s EPS (diluted) decreased by 200.0% year-over-year, from -$0.01 to -$0.03.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Turn Therapeutics Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude